Joseph E. Payne's most recent trade in Arcturus Therapeutics Holdings Inc was a trade of 196,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Hold... | Payne E. Joseph | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 196,000 | 196,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Payne Joseph E. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Joseph E. Payne | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Joseph E. Payne | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 16.51 per share. | 23 Nov 2022 | 5,000 | 1,480,097 (9%) | 0% | 16.5 | 82,550 | Common Stock |
| Arcturus Therapeutics Hold... | Joseph E. Payne | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Hold... | Joseph E. Payne | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 175,000 | 175,000 | - | - | Stock Option (right to buy) |